Knockdown of Circular RNAs Using LNA-Modified Antisense Oligonucleotides. 2023

Marianne Bengtson Løvendorf, and Anja Holm, and Andreas Petri, and Charlotte Albæk Thrue, and Shizuka Uchida, and Morten T Venø, and Sakari Kauppinen
Department of Clinical Medicine, Center for RNA Medicine, Aalborg University, Copenhagen, Denmark.

Circular RNAs (circRNAs) constitute an abundant class of covalently closed noncoding RNA molecules that are formed by backsplicing from eukaryotic protein-coding genes. Recent studies have shown that circRNAs can act as microRNA or protein decoys, as well as transcriptional regulators. However, the functions of most circRNAs are still poorly understood. Because circRNA sequences overlap with their linear parent transcripts, depleting specific circRNAs without affecting host gene expression remains a challenge. In this study, we assessed the utility of LNA-modified antisense oligonucleotides (ASOs) to knock down circRNAs for loss-of-function studies. We found that, while most RNase H-dependent gapmer ASOs mediate effective knockdown of their target circRNAs, some gapmers reduce the levels of the linear parent transcript. The circRNA targeting specificity can be enhanced using design-optimized gapmer ASOs, which display potent and specific circRNA knockdown with a minimal effect on the host genes. In summary, our results demonstrate that LNA-modified ASOs complementary to backsplice-junction sequences mediate robust knockdown of circRNAs in vitro and, thus, represent a useful tool to explore the biological roles of circRNAs in loss-of-function studies in cultured cells and animal models.

UI MeSH Term Description Entries
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D000079962 RNA, Circular RNA molecules in which the 3' and 5' ends are covalently joined to form a closed continuous loop. They are resistant to digestion by EXORIBONUCLEASES. Circular Intronic RNA,Circular RNA,Circular RNAs,Closed Circular RNA,ciRNA,circRNA,circRNAs,Circular RNA, Closed,Intronic RNA, Circular,RNA, Circular Intronic,RNA, Closed Circular,RNAs, Circular
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016376 Oligonucleotides, Antisense Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize. Anti-Sense Oligonucleotide,Antisense Oligonucleotide,Antisense Oligonucleotides,Anti-Sense Oligonucleotides,Anti Sense Oligonucleotide,Anti Sense Oligonucleotides,Oligonucleotide, Anti-Sense,Oligonucleotide, Antisense,Oligonucleotides, Anti-Sense

Related Publications

Marianne Bengtson Løvendorf, and Anja Holm, and Andreas Petri, and Charlotte Albæk Thrue, and Shizuka Uchida, and Morten T Venø, and Sakari Kauppinen
January 2015, Methods in molecular biology (Clifton, N.J.),
Marianne Bengtson Løvendorf, and Anja Holm, and Andreas Petri, and Charlotte Albæk Thrue, and Shizuka Uchida, and Morten T Venø, and Sakari Kauppinen
January 2003, Nucleosides, nucleotides & nucleic acids,
Marianne Bengtson Løvendorf, and Anja Holm, and Andreas Petri, and Charlotte Albæk Thrue, and Shizuka Uchida, and Morten T Venø, and Sakari Kauppinen
June 2014, Nucleic acid therapeutics,
Marianne Bengtson Løvendorf, and Anja Holm, and Andreas Petri, and Charlotte Albæk Thrue, and Shizuka Uchida, and Morten T Venø, and Sakari Kauppinen
March 2020, Molecular therapy. Nucleic acids,
Marianne Bengtson Løvendorf, and Anja Holm, and Andreas Petri, and Charlotte Albæk Thrue, and Shizuka Uchida, and Morten T Venø, and Sakari Kauppinen
April 2016, Nucleic acid therapeutics,
Marianne Bengtson Løvendorf, and Anja Holm, and Andreas Petri, and Charlotte Albæk Thrue, and Shizuka Uchida, and Morten T Venø, and Sakari Kauppinen
January 2017, Methods in molecular biology (Clifton, N.J.),
Marianne Bengtson Løvendorf, and Anja Holm, and Andreas Petri, and Charlotte Albæk Thrue, and Shizuka Uchida, and Morten T Venø, and Sakari Kauppinen
September 2012, Molecular therapy. Nucleic acids,
Marianne Bengtson Løvendorf, and Anja Holm, and Andreas Petri, and Charlotte Albæk Thrue, and Shizuka Uchida, and Morten T Venø, and Sakari Kauppinen
June 2019, Nucleic acid therapeutics,
Marianne Bengtson Løvendorf, and Anja Holm, and Andreas Petri, and Charlotte Albæk Thrue, and Shizuka Uchida, and Morten T Venø, and Sakari Kauppinen
November 2003, Nucleic acids research,
Marianne Bengtson Løvendorf, and Anja Holm, and Andreas Petri, and Charlotte Albæk Thrue, and Shizuka Uchida, and Morten T Venø, and Sakari Kauppinen
April 2011, Gene therapy,
Copied contents to your clipboard!